Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 800,126 |
|
|||||
| News | - | ||||||
| Day High | 36.12 | Low High |
|||||
| Day Low | 34.495 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| PTC Therapeutics Inc | PTCT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.22 | 0.62% | 35.62 | 23:00:03 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 35.42 | 34.495 | 36.12 | 35.62 | 35.40 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,735 | 800,126 | US$ 35.41 | US$ 28,333,753 | - | 17.53 - 44.66 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:00:17 | average | 90,793 | US$ 35.62 | USD |
PTC Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.73B | 76.61M | - | 1.07B | -626.6M | -8.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PTC Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTCT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 37.18 | 39.95 | 34.495 | 36.53 | 764,199 | -1.56 | -4.20% |
| 1 Month | 39.92 | 40.69 | 34.495 | 37.09 | 831,080 | -4.30 | -10.77% |
| 3 Months | 29.38 | 40.69 | 23.995 | 32.09 | 879,808 | 6.24 | 21.24% |
| 6 Months | 28.08 | 40.69 | 23.58 | 29.73 | 954,136 | 7.54 | 26.85% |
| 1 Year | 42.77 | 44.66 | 17.53 | 28.54 | 1,034,546 | -7.15 | -16.72% |
| 3 Years | 43.53 | 59.84 | 17.53 | 36.33 | 779,245 | -7.91 | -18.17% |
| 5 Years | 40.80 | 70.82 | 17.53 | 40.79 | 723,460 | -5.18 | -12.70% |
PTC Therapeutics Description
| PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |
